Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2018

01-05-2018 | Epidemiology

Assessment of potential risk factors for breast cancer in a population in Southern Brazil

Authors: Juliana Zeni Breyer, Eliana Marcia Wendland, Natália Luiza Kops, Maira Caleffi, Luciano Serpa Hammes

Published in: Breast Cancer Research and Treatment | Issue 1/2018

Login to get access

Abstract

Purpose

The aim of this study is to assess potential risk factors for breast cancer in a population in Southern Brazil and build a multivariate logistic model using these factors for breast cancer risk prediction.

Methods

A total of 4242 women between 40 and 69 years of age without a history of breast cancer were selected at primary healthcare facilities in Porto Alegre and submitted to mammographic screening. They were evaluated for potential risk factors.

Results

In all, 73 participants among the 4242 women had a breast cancer diagnosis during the follow-up of the project (10 years). The multivariate analysis considering all the patients aged 40–69 years showed that older age (OR 1.08, 95% CI 1.04–1.12), higher height (OR 1.04, 95% CI 1.01–1.09), and history of previous breast biopsy (OR 2.66, 95% CI 1.38–5.13) were associated with the development of breast cancer. Conversely, the number of pregnancies (OR 0.87, 95% CI 0.78–0.98) and use of hormone replacement therapy (OR 0.39, 95% CI 0.20–0.75) were considered a protective factor. Additionally, we performed an analysis separating the participants into groups of 40–49 and 50–69 years old, since a risk factor could have a specific behavior in these age groups. No additional risk factors were identified within these age brackets, and some factors lost statistical significance.

Conclusion

The risk prediction model indicates that the following variables should be assessed in this specific population: age, height, having had previous breast biopsies, number of pregnancies, and use of hormone replacement therapy. These findings may help to better understand the causal model of breast cancer in Southern Brazil.
Literature
8.
go back to reference Associação Brasileira de Empresas de Pesquisa (ABEP) (2012) Critério de Classificação Econômica Brasil Associação Brasileira de Empresas de Pesquisa (ABEP) (2012) Critério de Classificação Econômica Brasil
10.
go back to reference SAS (2016) SAS Institute Inc. 2016. SAS/STAT® 14.2 User’s Guide. Cary, NC: SAS Institute Inc SAS (2016) SAS Institute Inc. 2016. SAS/STAT® 14.2 User’s Guide. Cary, NC: SAS Institute Inc
12.
go back to reference National Breast and Ovarian Cancer Centre (2009) Breast cancer risk factors: a review of the evidence. National Breast and Ovarian Cancer Centre, Surry Hills, NSW National Breast and Ovarian Cancer Centre (2009) Breast cancer risk factors: a review of the evidence. National Breast and Ovarian Cancer Centre, Surry Hills, NSW
14.
17.
19.
go back to reference Gandini S, Merzenich H, Robertson C, Boyle P (1990) Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer Oxf Engl 36:636–646CrossRef Gandini S, Merzenich H, Robertson C, Boyle P (1990) Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer Oxf Engl 36:636–646CrossRef
21.
go back to reference Sepandi M, Akrami M, Tabatabaee H et al (2014) Breast cancer risk factors in women participating in a breast screening program: a study on 11,850 Iranian females. Asian Pac J Cancer Prev APJCP 15:8499–8502CrossRefPubMed Sepandi M, Akrami M, Tabatabaee H et al (2014) Breast cancer risk factors in women participating in a breast screening program: a study on 11,850 Iranian females. Asian Pac J Cancer Prev APJCP 15:8499–8502CrossRefPubMed
23.
go back to reference Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet Lond Engl 350:1047–1059CrossRef Collaborative Group on Hormonal Factors in Breast Cancer (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet Lond Engl 350:1047–1059CrossRef
Metadata
Title
Assessment of potential risk factors for breast cancer in a population in Southern Brazil
Authors
Juliana Zeni Breyer
Eliana Marcia Wendland
Natália Luiza Kops
Maira Caleffi
Luciano Serpa Hammes
Publication date
01-05-2018
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4655-0

Other articles of this Issue 1/2018

Breast Cancer Research and Treatment 1/2018 Go to the issue

Rebuttal Letter

Reply to K. Altundag

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine